Skip to main content

Want a detailed portfolio tracker?

Performance analysis of 4D Molecular Therapeutics (FDMT)

Annual Return

Over the past 3 years, FDMT has had an average annual return of -14.25%, underperforming the benchmark SPY, which returned +19.63% annual.

Over the past 5 years, FDMT has had an average annual return of -14.22%, underperforming the benchmark SPY, which returned +12.73% annual.

Since Dec 11, 2020, FDMT has had an average annual return of -20.25%, underperforming the benchmark SPY, which returned +15.18% annual.

2026202520242023202220212020
+51.67%+34.69%-72.51%-8.79%+1.24%-47.07%+2.35%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+18.14%+9%-3.61%-4.74%+11.74%+34.21%-14.46%+51.67%
2025+0.58%-19.09%-28.69%+4.26%+7.45%+2.46%+21.29%+36.90%+41.09%+32.34%+1.37%-35.67%+34.69%
2024-14.85%+62.46%+13.70%-24.89%+0.17%-12.43%-15.53%-15.35%-27.98%-25.89%-2.12%-28.98%-72.51%
2023-5.22%-8.60%-10.67%+4.78%+1.93%-1.57%+1.28%-11.04%-21.82%-15.62%+18.44%+59.25%-8.79%
2022-27.99%-13.28%+10.35%-21.22%-36.28%-8.06%+34.71%-16.37%+2.27%+7.71%+179.14%-8.11%+1.24%
2021+2.19%-0.90%+3.34%-10.78%-31.37%-9.33%+3.28%+22.83%-11.72%-10.90%-4.28%-4.61%-47.07%
2020+2.35%+2.35%

Drawdown analysis of 4D Molecular Therapeutics (FDMT)

The maximum drawdown for the FDMT was -95.23%, occurring on Apr 8, 2025. This drawdown has not yet recovered.

The current FDMT drawdown is -78.40%.

Since Dec 11, 2020 FDMT has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 2 times
  • 10% or more: 3 times
DepthStartTo BottomBottomTo RecoverEndTotal
-95.23%Feb 11, 20211043Apr 8, 2025OngoingOngoingOngoing
-23.57%Dec 18, 202011Jan 6, 20218Jan 19, 202119
-14.26%Jan 19, 20217Jan 28, 20215Feb 4, 202112
-5.58%Feb 5, 20212Feb 9, 20212Feb 11, 20214
-5.11%Dec 11, 20203Dec 16, 20202Dec 18, 20205